BRÈVE

sur Zomedica Corp. (NASDAQ:ZOM)

Zomedica Receives CE Certification for VetGuardian® System, Expands in European Market

Zomedica Corp, a veterinary health company, has announced its receipt of CE certification for the VetGuardian® system, paving the way for expansion across the European Union. This certification confirms that VetGuardian meets all EU health, safety, and environmental standards, which could greatly enhance veterinary care in the region.

The VetGuardian system utilizes innovative radar technology to monitor animal vital signs contactlessly, aiming to reduce stress during monitoring and increase clinical efficiency. According to Tony Blair, Chief Operating Officer, this certification not only broadens market potential but also equips veterinarians with advanced tools to improve patient and operational care.

This strategic advancement comes as the European veterinary market shows promising growth forecasts, with expectations to rise from $4 billion in 2022 to $5.4 billion by 2027. With the CE mark, Zomedica anticipates accelerated global expansion for its VetGuardian product, responding to widespread customer interest and increasing demand.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Zomedica Corp.